Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,989.7
15.8 (0.53%)

 

  • STI Straits Times Index
    2,989.7
    15.8 (0.53%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,574.0
    4.1 (0.26%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    29,571.6
    475.8 (1.64%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,547.5
    38.9 (1.11%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    29,459.7
    51.5 (0.18%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,361.9
    2.7 (0.04%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,479.7M
  • Value: 472.2M
  • Rise: 89
  • Fall: 134
  • Unch: 551

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Oceanus^0.043-0.021
Thomson Medical0.108-0.009
Jiutian Chemical0.084-0.003
CWX Global0.005-
Asian Pay Tv Tr0.105-0.004
Anchor Resources0.015-
AusGroup0.026-0.001
Beverly JCG0.001-
Keppel Reit1.150-
Golden Agri-Res0.191+0.001

World Indices

World Indices
Name Last Change
Nasdaq 13,358.8 -230.0
HSI 29,654.0 +558.1
HSCEI 11,561.0 +199.6
Jakarta 6,370.1 +10.9
Nikkei 225 29,459.7 +51.5
SSE Comp 3,547.3 +38.7
Shanghai A 3,718.3 +40.5
Shanghai B 247.7 +2.0
KOSPI 3,053.8 +9.9

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

Biolidics BIOLIDICS LIMITED
Quotes 10 Minutes Delayed. Updated at 03 Mar 2021 11:15
Last (SGD): 0.280 Change: - High: 0.280 Remarks: -
Change (%): - Low: 0.280
Open 0.280 Yesterday's Close 0.280
Buy Price 0.275 Sell Price 0.280
Buy Volume ('000) 273.9 Sell Volume ('000) 0.8
Cumulative Volume ('000) 123.4 Cumulative Value 34,552
Click to show Stock Prices chart

Key Statistics

EPS (SGD) a -0.01761 Trailing EPS (SGD) e -0.01761 NAV (SGD) b 0.0313
PE a - Trailing PE f - Price / NAV b 8.9457
Dividend (SGD) d - Cash In Hand (SGD) g 0.0404 Issued & Paid-up Shares c 264,047,000
Dividend Yield (%) d - Price / Cash In Hand g 6.931 Treasury Shares h -
Beta - 75 Daysi 0.170 R-Squared - 75 Days(%)i 0.12 Market Cap (M) 73.933
Beta - 500 Daysi 0.365 R-Squared - 500 Days (%)i 0.61 Enterprise Value (M) 68.540
Piotroski F Score 2 Exchange Code 8YY Par Value ( SGD ) n.a.
52 Weeks Volatility (%) 78.5501 6-Month VWAP 0.332 Free Float (%) 34.0
Under CPF Investment Scheme (CPFIS) No
Sector & Industry Prof, Scientific & Technical Activities - Medical Specialties
Category Classification Medical & Biotechnology
Index Components FTSE ST Catalist Index
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 02 Mar 2021.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand.
  9. Beta and R-Squared are calculated in relation to the market index (STI or KLCI) using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference Biolidics SGX 73.933 - - 8.9457 -
Industry Medical & Biotechnology SGX 974.690 21.214 22.339 1.4071 1.955
Medical Specialties SGX 2,311.250 22.601 9.456 6.4514 2.268
Index FTSE ST Catalist Index SGX 56.054 30.063 88.683 1.2971 1.315
Local Peer Top Glove SGX 13,201.643 21.745 9.769 7.2527 2.372
Local Peer Medtecs Intl SGX 541.170 345.614 9.799 3.8312 -
Local Peer UGHealthcare SGX 366.674 27.356 5.433 2.8869 0.382
Local Peer Annica SGX 16.675 - - 5.0000 -
Local Peer Yunnan Energy SGX 16.251 - - 0.3360 -
Global Peer ABBOTT LABORATORIES NYSE 217,065.571 48.528 48.528 6.6211 1.248
Global Peer THERMO FISHER SCIENTIFIC INC NYSE 181,975.683 28.545 28.545 5.2736 0.192
Global Peer DANAHER CORP NYSE 159,597.794 45.469 45.469 4.3728 0.321
Global Peer MEDTRONIC PLC NYSE 158,826.289 33.165 54.919 3.1291 1.891
Global Peer STRYKER CORP NYSE 92,315.963 57.734 57.734 7.0556 0.959
Global Peer INTUITIVE SURGICAL INC NASDAQ 88,288.500 83.244 83.244 9.0724 -
Global Peer BECTON DICKINSON & CO NYSE 71,108.749 92.710 47.154 2.8835 1.305
Global Peer BOSTON SCIENTIFIC CORP NYSE 54,929.509 - - 3.5838 -
Global Peer EDWARDS LIFESCIENCES CORP NYSE 53,883.499 65.440 65.440 11.7796 -
Global Peer KONINKLIJKE PHILIPS NV ADR EACH REP 1 ORD EUR0.20 NYSE 50,290.126 37.165 37.165 3.4627 1.859
Other Global Peers IDEXX LABORATORIES INC (NASDAQ), ALIGN TECHNOLOGY INC (NASDAQ), BAXTER INTERNATIONAL INC (NYSE), DEXCOM INC (NASDAQ), AGILENT TECHNOLOGIES INC (NYSE), ALCON AG (NYSE), ZIMMER BIOMET HOLDINGS INC (NYSE), RESMED INC (NYSE), METTLER-TOLEDO INTERNATIONAL INC (NYSE), GENMAB AS SPON ADS EACH REP 0.1 ORD SHS (NASDAQ), WEST PHARMACEUTICAL SERVICES INC (NYSE), HOLOGIC INC (NASDAQ), COOPER COS INC (NYSE), TELEFLEX INC (NYSE), INSULET CORPORATION (NASDAQ), BIO RAD LABORATORIES INC (NYSE), WATERS CORP (NYSE), SMITH & NEPHEW ADR EACH REPR 2 ORD (NYSE), VARIAN MEDICAL SYSTEMS INC (NYSE), NOVOCURE LTD (NASDAQ), STERIS PLC (NYSE), ABIOMED INC (NASDAQ), PERKINELMER INC (NYSE), MASIMO CORPORATION (NASDAQ), DENTSPLY SIRONA INC (NASDAQ), FISHER & PAYKEL HEALTHCARE CORP (ASX), QIAGEN NV (NYSE), COCHLEAR LTD (ASX), MICROPORT (HKEx), PENUMBRA INC (NYSE), BRUKER CORPORATION (NASDAQ), TOPGLOV (Bursa), HARTA (Bursa), WEIGAO GROUP (HKEx), SOTERA HEALTH CO (NASDAQ), HILL-ROM HOLDINGS INC (NYSE), QUIDEL CORP (NASDAQ), INSPIRE MEDICAL SYSTEMS INC (NYSE), HAEMONETICS CORP (NYSE), ENVISTA HOLDINGS CORPORATION (NYSE), GLOBUS MED INC (NYSE), TANDEM DIABETES CARE INC (NASDAQ), NEVRO CORP (NYSE), INTEGRA LIFESCIENCES HLDGS CORP (NASDAQ), CARDIOFLOW-B (HKEx), INARI MEDICAL INC (NASDAQ), STAAR SURGICAL CO (NASDAQ), CAREDX INC (NASDAQ), NEOGEN CORP (NASDAQ), IRHYTHM TECHNOLOGIES INC (NASDAQ), GLAUKOS CORPORATION (NYSE), ICU MEDICAL INC (NASDAQ), SHOCKWAVE MEDICAL INC (NASDAQ), ORTHO CLINICAL DIAGNOSTCS HLDGS PLC (NASDAQ), VENUS MEDTECH-B (HKEx), LIVANOVA PLC (NASDAQ), BUTTERFLY NETWORK INC (NYSE), CONMED CORP (NYSE), EBOS GROUP (ASX), CANTEL MEDICAL CORP (NYSE), NUVASIVE INC (NASDAQ), MERIT MEDICAL SYSTEMS (NASDAQ), ATRICURE INC (NASDAQ), INMODE LTD (NASDAQ), SUPERMX (Bursa), INOVIO PHARMACEUTICALS INC (NASDAQ), AVANOS MEDICAL INC (NYSE), VERICEL CORP (NASDAQ), OUTSET MEDICAL INC (NASDAQ), EARGO INC (NASDAQ), PULMONX CORPORATION (NASDAQ), LIFETECH SCI (HKEx), AXONICS MODULATION TECHNLOGS INC (NASDAQ), PEIJIA-B (HKEx), NANO-X IMAGING LTD (NASDAQ), HESKA CORP (NASDAQ), SILK ROAD MEDICAL INC (NASDAQ), KANGJI MEDICAL (HKEx), CARDIOVASCULAR SYSTEMS INC DEL (NASDAQ), DERMTECH INC (NASDAQ), ESTABLISHMENT LABS HLDGS INC (NASDAQ), AK MEDICAL (HKEx), 908 DEVICES INC (NASDAQ), NANOSONICS LIMITED (ASX), MESA LABORATORIES INC (NASDAQ), GENMARK DIAGNOSTICS INC (NASDAQ), BIOLIFE SOLUTIONS INC (NASDAQ), ALPHATEC HLDGS INC (NASDAQ), LANTHEUS HOLDINGS INC (NASDAQ), INOGEN INC (NASDAQ), ATRION CORP (NASDAQ), CIRC (HKEx), CELLDEX THERAPEUTICS INC (NASDAQ), CERUS CORP (NASDAQ), ORTHOPEDIATRICS CORP (NASDAQ), LEMAITRE VASCULAR INC (NASDAQ), SI BONE INC (NASDAQ), TACTILE SYSTEMS TECHNOLOGY INC (NASDAQ), CRYOLIFE INC (NYSE), TRANSMEDICS GROUP INC (NASDAQ), VAREX IMAGING CORPORATION (NASDAQ), BASECARE-B (HKEx), AXOGEN INC (NASDAQ), KDL MEDICAL (HKEx), CHUNLI MEDICAL (HKEx), ORTHOFIX MEDICAL INC (NASDAQ), NATUS MEDICAL INC (NASDAQ), INFUSYSTEM HOLDINGS INC (NYSE American), ANGIODYNAMICS INC (NASDAQ), ORASURE TECHNOLOGIES INC (NASDAQ), PULSE BIOSCIENCES INC (NASDAQ), ANTARES PHARMA INC (NASDAQ), VIEWRAY INC (NASDAQ), LUCIRA HEALTH INC (NASDAQ), BIOVENTUS INC (NASDAQ), SURMODICS INC (NASDAQ), VAPOTHERM INC (NYSE), CUTERA INC (NASDAQ), ACCELERATE DIAGNOSTICS INC (NASDAQ), ACUTUS MEDICAL INC (NASDAQ), STEREOTAXIS INC (NYSE American), SEASPINE HOLDINGS CORP (NASDAQ), OXFORD IMMUNOTEC GLOBAL PLC (NASDAQ), RETRACTABLE TECHNOLOGIES INC (NYSE American), ZYNEX INC (NASDAQ), ACCURAY INCORPORATED (NASDAQ), MEDAVAIL HOLDINGS INC (NASDAQ), AVADEL PHARMACEUTICALS PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), QUOTIENT LTD (NASDAQ), AVITA THERAPEUTICS INC (NASDAQ), PROFOUND MED CORP (NASDAQ), CLEARPOINT NEURO INC (NASDAQ), MCP INCOME OPPORTUNITIES TRUST (ASX), SIENTRA INC (NASDAQ), TALIS BIOMEDICAL CORP (NASDAQ), CYTOSORBENTS CORP (NASDAQ), NEURONETICS INC (NASDAQ), ITAMAR MEDICAL LTD SPON ADS EACH REP 30 ORD SHS (NASDAQ), APYX MEDICAL CORPORATION (NASDAQ), YESTAR HEALTH (HKEx), FLUIDIGM CORP DEL (NASDAQ), PAVMED INC (NASDAQ), CLEANSPACE HOLDINGS LTD (ASX), INVACARE CORP (NYSE), UTAH MEDICAL PRODUCTS (NASDAQ), MISONIX INC (NASDAQ), MEDICAL DEVELOPMENT INTL (ASX), IRADIMED CORP (NASDAQ), CORMEDIX INC (NASDAQ), AROA BIOSURGERY LTD (ASX), SURGALIGN HOLDINGS INC (NASDAQ), SOLITON INC (NASDAQ), DARIOHEALTH CORP (NASDAQ), VOLPARA HEALTH TECHNOLOGIES LTD (ASX), ENLIVEX THERAPEUTICS LTD (NASDAQ), TELA BIO INC (NASDAQ), INTRICOM CORP (NASDAQ), ALPHA PRO TECH (NYSE American), TITAN MEDICAL INC (NASDAQ), SOLENO THERAPEUTICS INC (NASDAQ), ATOSSA THERAPEUTICS INC (NASDAQ), NYMOX PHARMACEUTICALS CORP(BAHAMAS) (NASDAQ), CYCLOPHARM LIMITED (ASX), CONFORMIS INC (NASDAQ), INCANNEX HEALTHCARE LTD (ASX), MODERN DENTAL (HKEx), REPRO MEDSYSTEMS INC (NASDAQ), NEMAURA MEDICAL INC (NASDAQ), AVINGER INC (NASDAQ), APOLLO ENDOSURGERY INC (NASDAQ), ONCOCYTE CORP (NYSE American), BIOLASE INC (NASDAQ), VINCENT MED (HKEx), IMAGION BIOSYSTEMS LIMITED (ASX), MICRO-X LTD (ASX), VENUS CONCEPT INC (NASDAQ), FONAR CORP (NASDAQ), BIOSIG TECHNOLOGIES INC (NASDAQ), KELFRED (HKEx), CELSION CORPORATION (NASDAQ), ZOSANO PHARMA CORP (NASDAQ), EMVISION MEDICAL DEVICES LTD (ASX), ROCKWELL MEDICAL INC (NASDAQ), COLLPLANT BIOTECHNOLOGIES LTD SPON ADS EACH REP 1 ORD SHS (NASDAQ), PW MEDTECH (HKEx), MILESTONE SCIENTIFIC INC (NYSE American), IMPEDIMED LIMITED (ASX), TRINITY BIOTECH PLC ADR EACH REPR 4 CLS A ORD USD0.019 (NASDAQ), ELECTROCORE INC (NASDAQ), SOMNOMED LIMITED (ASX), DELCATH SYSTEMS INC (NASDAQ), LIANLUO SMART LIMITED (NASDAQ), OPTISCAN IMAGING (ASX), VOLITIONRX LIMITED (NYSE American), CHEMBIO DIAGNOSTICS INC (NASDAQ), BRAINSWAY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), ATOMO DIAGNOSTICS LIMITED (ASX), REWALK ROBOTICS LTD (NASDAQ), NEOVASC INC (NASDAQ), LENSAR INC (NASDAQ), ELECTROMED INC (NYSE American), EKSO BIONICS HOLDINGS INC (NASDAQ), IRIDEX CORP (NASDAQ), IMMUCELL CORP (NASDAQ), APPLIED UV INC (NASDAQ), SENSUS HEALTHCARE INC (NASDAQ), NEPHROS INC (NASDAQ), BIOMERICA INC (NASDAQ), XTANT MEDICAL HLDGS INC (NYSE American), RESPIRI LTD (ASX), SDI LTD (ASX), RGTBHD (Bursa), CHECK-CAP LTD (NASDAQ), RESONANCE HEALTH LTD (ASX), CANCER GENETICS INC (NASDAQ), HELIUS MEDICAL TECHNOLOGIES INC (NASDAQ), BELLEROPHON THERAPEUTICS INC (NASDAQ), CARDIEX LTD (ASX), STRATA SKIN SCIENCES INC (NASDAQ), PREDICTIVE ONCOLOGY INC (NASDAQ), COMPUMEDICS (ASX), UNIVERSAL BIOSENSORS INC NPV (CDI) (ASX), HANCOCK JAFFE LABORATORIES INC (NASDAQ), SINTX TECHNOLOGIES INC (NASDAQ), LKL (Bursa), MEDIGUS SPON ADS EACH REP 50 ORD SHS (POST SPLT) (NASDAQ), MOTUS GI HOLDINGS INC (NASDAQ), DAXOR CORP (NYSE American), SECOND SIGHT MEDICAL PRODUCTS INC (NASDAQ), DIMERIX LTD (ASX), NOVA EYE MEDICAL LIMITED (ASX), OSPREY MEDICAL INC NPV (CHESS DEPOSITARY INTERESTS) (ASX), RESAPP HEALTH LIMITED (ASX), TENAX THERAPEUTICS INC (NASDAQ), NEUROTECH INTERNATIONAL LTD (ASX), AKERS BIOSCIENCES INC (NASDAQ), ALLEGRA ORTHOPAEDICS LIMITED (ASX), OBALON THERAPEUTICS INC (NASDAQ), AETHLON MEDICAL INC (NASDAQ), NANOVIBRONIX INC (NASDAQ), VIVEVE MEDICAL INC (NASDAQ), OVENTUS MEDICAL LTD (ASX), LIFE HEALTHCARE (HKEx), LBT INNOVATIONS LTD (ASX), TRUSCREEN GROUP LTD (ASX), CYANOTECH CORP (NASDAQ), THERMOGENESIS HOLDINGS INC (NASDAQ), CHF SOLUTIONS INC (NASDAQ), DYNATRONICS CORP (NASDAQ), RA MEDICAL SYSTEMS INC (NYSE American), ALLIED HEALTHCARE PRODUCTS INC (NASDAQ), USCOM LTD (ASX), METALICITY LIMITED (ASX), STAR EQUITY HOLDINGS INC (NASDAQ), NEUROMETRIX INC (NASDAQ), ADHERIUM LIMITED (ASX), DORSAVI LTD (ASX), ANALYTICA (ASX), INSPIREMD INC (NYSE American), HUAKANG BIOMED (HKEx), STHAI (SET)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --0.030
-9.68 %
10 Days --0.030
-9.68 %
20 Days --0.030
-9.68 %
Medium Term Return 3 Months --0.070
-20.00 %
6 Months --0.090
-24.32 %
1 Year -+0.060
+27.27 %
Long Term Return 2 Years ---
Annualised Return Annualised ---
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 0.175 - 0.885 Change From 1 Year Low +0.105 % Change From 1 Year Low (%) +60.00
Change From 1 Year High -0.605 % Change From 1 Year High (%) -68.36
2 Years Range 0.175 - 0.885 Change From 2 Years Low +0.105 % Change From 2 Years Low (%) +60.00
Change From 2 Years High -0.605 % Change From 2 Years High (%) -68.36
5 Years Range 0.175 - 0.885 Change From 5 Years Low +0.105 % Change From 5 Years Low (%) +60.00
Change From 5 Years High -0.605 % Change From 5 Years High (%) -68.36
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

The Company is a Singapore-based medical technology company focusing on the development of cell enrichment systems which, when combined with other analytical tests, have a wide range of applications for cancer diagnosis, prognosis, treatment selection and treatment monitoring. The Company aspires to impact the lives of patients through the provision of diagnostic solutions in every cancer centre worldwide.The Company has developed the ClearCell FX1 System, a fully automated IVD medical device which relies on a novel patented technology to separate and enrich cancer cells from blood. This allows users of the system to perform liquid biopsies to test for the presence of cancer cells (specifically circulating tumour cells, or CTCs) in blood samples or perform further analysis on cancer cells, providing a simple and minimally invasive alternative to tissue biopsies, which involve the surgical removal of tissue from a patients body.

IPO Performance

Listing Date 19 Dec 2018 Full Subscription Rate (x) -
No of Placement Shares (M) 27.50 No of Public Offer Shares (M) - Public Offer Subscription Rate (x) -
IPO Price (SGD) 0.280 First Day Close (SGD) 0.235 First Week Close (SGD) 0.230
Current vs IPO Price (%) - First Day Gain (%) -16.07 First Week Gain (%) -17.86

Reports Download

Report Type Financial Year Ended Download
Annual Report
Annual Report 2019 Dec 2019 Part 1(5.32 MB)
Annual Report 2018 Dec 2018 Part 1(3.41 MB)
IPO Prospectus
IPO Prospectus 2018 Dec 2018 Part 1(2.88 MB)
Part 2(0.53 MB)

Historical Price Data

Date Open High Low Close Volume VWAP
02 Mar 2021 0.285 0.285 0.280 0.280 471,300 0.2819
01 Mar 2021 0.290 0.290 0.280 0.290 1,600,500 0.2857
26 Feb 2021 0.300 0.300 0.295 0.295 708,600 0.2980
25 Feb 2021 0.300 0.305 0.295 0.295 1,746,400 0.3019
24 Feb 2021 0.310 0.310 0.300 0.305 1,063,900 0.3056
23 Feb 2021 0.310 0.310 0.310 0.310 164,000 0.3100
22 Feb 2021 0.320 0.320 0.315 0.320 592,000 0.3180
19 Feb 2021 0.325 0.325 0.315 0.320 1,347,500 0.3222
18 Feb 2021 0.310 0.330 0.310 0.325 1,655,900 0.3170
17 Feb 2021 0.310 0.315 0.305 0.310 701,400 0.3105
16 Feb 2021 0.305 0.315 0.305 0.310 1,026,900 0.3086
15 Feb 2021 0.315 0.315 0.305 0.305 333,600 0.3066
11 Feb 2021 0.310 0.315 0.305 0.310 120,900 0.3098
10 Feb 2021 0.305 0.320 0.305 0.310 1,469,200 0.3097
09 Feb 2021 0.300 0.310 0.300 0.305 944,900 0.3044
08 Feb 2021 0.310 0.310 0.300 0.300 697,200 0.3026
05 Feb 2021 0.310 0.310 0.305 0.310 284,000 0.3058
04 Feb 2021 0.310 0.315 0.300 0.305 1,148,500 0.3058
03 Feb 2021 0.310 0.315 0.310 0.315 764,600 0.3106
02 Feb 2021 0.320 0.320 0.305 0.310 1,250,500 0.3113
01 Feb 2021 0.305 0.315 0.300 0.310 1,010,700 0.3081
29 Jan 2021 0.315 0.320 0.305 0.305 1,423,000 0.3091
Summary
Current 2 Weeks
(17 Feb 2021 to 02 Mar 2021)
0.310 0.330 0.280 0.280 10,051,500 -
Previous 2 Weeks
(02 Feb 2021 to 16 Feb 2021)
0.320 0.330 0.280 0.310 8,040,300 -
4 Weeks from
(05 Jan 2021 to 01 Feb 2021)
0.300 0.330 0.280 0.310 40,849,400 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.